Biotest is a company specialising
in innovative haematology and immunology products with the holistic
of a global pharmaceutical, diagnostics and biotherapeutics group. Its
approximately 1,200 employees develop, manufacture and sell medicinal
for the treatment of blood and immune diseases as well as reagents and
systems for diagnostic purposes in transfusion and transplantation
Biotest is, in addition, one of the leading manufacturers of products
the hygiene monitoring of air and work surfaces.
most important starting
material for our pharmaceutical products is human blood plasma which we
process into effective and highly pure medicinal products in one of the
world’s most modern production facilities in Europe. Our products are
in the treatment of life-threatening diseases such as coagulation
(haemophilia), severe infections or disorders of the immune system. One
of our highest priority research projects is the development of
antibodies, active substances produced by biotechnological techniques,
which will open up new prospects in the treatment of rheumatism,
and other autoimmune diseases.
the highest standards and are sold in markets which have to satisfy the
most stringent registration requirements in the world. Patients,
medical practices, laboratories and companies in 159 countries around
globe put their trust in Biotest’s quality and safety.